Insiders Who Purchased CN¥15.3m Of Jiangsu Recbio Technology Stock May Not Have Expected 11% Tumble

Simply Wall St.06-03

Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) stock at an average buy price of CN¥6.43 over the last year may be disappointed by the recent 11% decrease in the...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2640975319?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","is_english":true,"pubTime":"2026-06-03 10:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640975319","market":"sg","top_or_hot":-1,"title":"Insiders Who Purchased CN¥15.3m Of Jiangsu Recbio Technology Stock May Not Have Expected 11% Tumble","media":"Simply Wall St.","content":"<div>\n<p>Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) stock at an average buy price of CN¥6.43 over the last year may be disappointed by the recent 11% decrease in the...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insiders Who Purchased CN¥15.3m Of Jiangsu Recbio Technology Stock May Not Have Expected 11% Tumble</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsiders Who Purchased CN¥15.3m Of Jiangsu Recbio Technology Stock May Not Have Expected 11% Tumble\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-03 10:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) stock at an average buy price of CN¥6.43 over the last year may be disappointed by the recent 11% decrease in the...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CN","symbol_name":"Xtrackers MSCI All China Equity ETF","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s","article_id":"2640975319","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2179/jiangsu-recbio-technology-shares/news/insiders-who-purchased-cn153m-of-jiangsu-recbio-technology-s","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2640975319","pubTimestamp":1780455487,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s ( HKG:2179 ) stock at an average buy price...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"CN":"Xtrackers MSCI All China Equity ETF","02179":"瑞科生物-B","BK1161":"生物科技"},"translate_title":"购买了1,530万元人民币江苏瑞生物科技股票的内部人士可能没有预料到股价会暴跌11%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02179":1,"CN":1.5},"content_text":"Insiders who bought CN¥15.3m worth of Jiangsu Recbio Technology Co., Ltd.'s (HKG:2179) stock at an average buy price of CN¥6.43 over the last year may be disappointed by the recent 11% decrease in the stock.  This is not good as insiders invest based on expectations that their money will appreciate over time. However, as a result of recent losses, their original investment is now worth only CN¥10.5m.     While insider transactions are not the most important thing when it comes to long-term investing,  we do think it is perfectly logical to keep tabs on what insiders are doing.  Trump has pledged to \"unleash\" American oil and gas and these 15 US stocks have developments that are poised to benefit.Advertisement Jiangsu Recbio Technology Insider Transactions Over The Last Year   Over the last year, we can see that the biggest insider purchase was by Non-Executive Chairman Haoyu Xu for HK$12m worth of shares, at about HK$7.86 per share.    That means that an insider was happy to buy shares at above the current price of HK$4.44.  While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future.  In our view, the price an insider pays for shares is very important.   Generally speaking, it catches our eye when an insider has purchased shares at above current prices, as it suggests they believed the shares were worth buying, even at a higher price.  The only individual insider to buy over the last year was Haoyu Xu.       Haoyu Xu bought 2.37m shares over the last 12 months at an average price of HK$6.43.   You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below.  If you want to know exactly who sold, for how much, and when, simply click on the graph below!  See our latest analysis for Jiangsu Recbio Technology SEHK:2179 Insider Trading Volume June 3rd 2026 There are always plenty of stocks that insiders are buying. If investing in lesser known companies is your style, you could take a look at this free list of companies. (Hint: insiders have been buying them).   Insider Ownership Of Jiangsu Recbio Technology  Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own.  We usually like to see fairly high levels of insider ownership.   Based on our data, Jiangsu Recbio Technology insiders have about 1.4% of the stock, worth approximately HK$38m.   However, it's possible that insiders might have an indirect interest through a more complex structure.   We consider this fairly low insider ownership.   So What Do The Jiangsu Recbio Technology Insider Transactions Indicate?  There haven't been any insider transactions in the last three months -- that doesn't mean much.    However, our analysis of transactions over the last year is heartening.   Overall we don't see anything to make us think Jiangsu Recbio Technology insiders are doubting the company, and they do own shares.      So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company.    When we did our research, we found 4 warning signs for Jiangsu Recbio Technology (2 can't be ignored!) that we believe deserve your full attention.   But note: Jiangsu Recbio Technology may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2640975319","isCrawlerRequest":true}